Synthesis, Stereochemical Characterization, and Antimicrobial Evaluation of a Potential Non-Nephrotoxic 3'-c-acethydrazide Puromycin Analog

Josh Carter, Blair A. Weaver, Maria A. Chiacchio, Amy R. Messersmith, Will E. Lynch, Brent D. Feske, Giuseppe Gumina

Research output: Contribution to journalArticlepeer-review

Abstract

Puromycin is a peptidyl nucleoside endowed with significant antibiotic and anticancer properties, but also with an unfortunate nephrotoxic character that has hampered its use as a chemotherapeutic agent. Since hydrolysis of puromycin's amide to puromycin aminonucleoside is the first metabolic step leading to nephrotoxicity, we designed a 3′-C-hydrazide analog where the nitrogen and carbon functionality around the amide carbonyl of puromycin are inverted. The title compound, synthesized in 11 steps from D-xylose, cannot be metabolized to the nephrotoxic aminonucleoside. Evaluation of the title compound on Staphylococcus epidermidis and multi-drug resistance Staphylococcus aureus did not show significant antimicrobial activity up to a 400 μM concentration.

Original languageAmerican English
JournalJournal of Nucleosides, Nucleotides and Nucleic Acids
Volume36
DOIs
StatePublished - Jan 1 2017

Keywords

  • Antimicrobial evaluation
  • Potential non-nephrotoxic 3'-C-acethydrazide puromycin analog
  • Stereochemical characterization
  • Synthesis

DC Disciplines

  • Chemistry

Fingerprint

Dive into the research topics of 'Synthesis, Stereochemical Characterization, and Antimicrobial Evaluation of a Potential Non-Nephrotoxic 3'-c-acethydrazide Puromycin Analog'. Together they form a unique fingerprint.

Cite this